NIV Reduces CBF in COPD Patients Without Cognitive Function

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 1, 2007

Primary Completion Date

May 1, 2011

Study Completion Date

May 31, 2011

Conditions
COPDNon-invasive VentilationCognitive ImpairmentCerebral Blood Flow
Interventions
OTHER

Non-invasive ventilation

NIV was provided by BiPAP-Vision™ ventilator (Philips Respironics Inc, Murrysville, PA, USA) set at the BIPAP mode and applied by a nasal mask, with room air, for 60 minutes. Volunteers were studied during the application of NIV (inspiratory pressure of 14cmH2O and expiratory pressure of 4cmH2O), with a pressure support of 10cmH2O and without oxygen support (FIO2 0.21). These pressure levels were chosen based on the current practice of NIV in the intensive care setting.

All Listed Sponsors
lead

Universidade Federal do Ceara

OTHER

NCT03149835 - NIV Reduces CBF in COPD Patients Without Cognitive Function | Biotech Hunter | Biotech Hunter